FCPIOfficial’s Post

Are you attending #EMWA57 #EMWAconference, Valencia May 2024? We are running the free #COREReference session on Symposium Day - Thursday 09 May - from 09.00-10.30. If you registered for the Symposium, this precluded you from signing up for the simultaneous #COREReference session. However, if you wish to drop by you are most welcome, and we ask that you email to emwaconference@emwa.org with a note of your intention to help us more accurately estimate the number of potential participants. Agenda:  * Value of #COREReference for #Disclosure-Ready #clinicalstudyreports & Continuing #Professionaldevelopment (CPD) resources * Real life #Policy0070 submissions, including planned versus actual timeline * #Policy0070 Re-launch: Anonymisation Report (AnR) Template and insights on completion * #Medicaldevices CPD, including MD and drugs spaces intersection * #COREReference 2023 Utility Survey Results – An Overview * Breaking news (including the launch of the revised CTIS transparency rules and new CTIS website in June 2024 and the new draft guidance on PPD and CCI within the MAA dossier). We hope to see you on the day. Dr Sam Hamilton, Chair CORE Reference Project

😊LIVE TODAY: Introduction to Shock by Dr. Shubham Kandhare, Pharm D - 2nd presentation from the critical care medicine basic module.

I note some are calling for all medicines to be listed on the PBS within 60 days of approval by the TGA. A close examination of the agenda for the July 2024 PBAC meeting indicates this will not occur anytime soon. Of the 15 submissions to list a new medicine or new combination product on the PBS, one was registered by the TGA in 2014 and another in 2021. For all medicines to be listed on the PBS within 60 days of TGA approval, all submissions for new medicines will need to be submitted under the TGA-PBAC parallel process. #medicine #marketaccess #timelines #reimbursement #hta #healthtechnology #data #datascience #PBS #PBAC #TGA

Under the auspices of #EHA with the brilliant leadership of H.E Dr Ahmed Elsobky, We are pleased to announce the launch of EGAAP phase 2. "Phase 2" is a promising extension to the successful achievement of "Phase 1" which was held during 2023. hereunder are the new standards and details added to Phase 2 to maintain the successful journey towards green practice. What is new about Phase TWO of EGAPP? 1. Adding more Standards: a. Drug and Therapeutic Committee. b. Antibiotic Stewardship. c. Medication Preparation. d. Medication Utilization improvement project. 2. Adding two Separate competitions: a. Best Antibiotic Stewardship Program. b. Best Medication Utilization improvement project. 3. Adding the Concept of : White List and Green List • White list : this list shall include all new hospitals which needs to be oriented and educated about the competition standards and how exactly to implement them .(i.e., Learners ) • Green list : this list shall include GAHAR accredited hospitals and EGAPP awarded hospitals which are willing to help and guide one or more of the hospitals in the white list to get more oriented and educated about the competition standards and how exactly to implement them. (i.e., Mentors) • Whenever any of the whitelist hospitals gets recognized or awarded as an EGAPP Winner, their mentors shall be recognized or awarded at the same levels of awarding or recognition. Stay tuned to know more about the competition and how to register. Ahmed Safwat Sherif Kamal #EGAPP #Green_Award

A quick reminder to those attending #EMWA57 #EMWAconference, Valencia May 2024. Free #COREReference session on Symposium Day - Thursday 09 May - from 09.00-10.30. If you registered for the Symposium, this precluded you from signing up for the simultaneous #COREReference session. However, if you wish to drop by you are most welcome; just email emwaconference@emwa.org with a note of your intention. The agenda: * Value of #COREReference for #Disclosure-Ready #clinicalstudyreports & Continuing #Professionaldevelopment (CPD) resources * Real life #Policy0070 submissions, including planned versus actual timeline * #Policy0070 Re-launch: Anonymisation Report (AnR) Template and insights on completion * #Medicaldevices CPD, including MD and drugs spaces intersection * #COREReference 2023 Utility Survey Results – An Overview * Breaking news (including the launch of the revised #CTIStransparencyrules and new CTIS website in June 2024 and the new draft guidance on PPD and CCI within the MAA dossier). Looking forward seeing you on the day.

I have earned Blackmores Institute CMEd certified badge! Credly by Pearson The Blackmores Institute CMEd Certification badge is awarded to Pharmacists who have completed the CMEd Ingredients and CMEd Health Conditions badges and have successfully completed a case study based final assessment. Earners have applied the knowledge gained in the CMEd certification program to manage common conditions encountered in the pharmacy. This has been achieved through the construction of an integrated management plan incorporating evidence based complementary medicines. #learninganddevelopment #onlinecourses #certification #pharmacists #complementarymedicine

In the Nordic countries the risk from falsified medicines is real, but only when you buy your medicine from unauthorised and illegal sources. If you buy your medicine from an approved pharmacy, you can be confident that your medicine is authentic. The Nordic NMVOs provide secure, straightforward and supportive systems for verifying medicines. The system alerts if a falsified medicine should turn up and warns if medicines already dispensed or destroyed are dispensed. The system can also be used to ensure that packs from recalled batches never reach the patient. This results in an additional quality control in the medicine handling process. Together we help to make sure every individual can have confidence in their medicine. The Nordic NMVOs have recently updated our “Nordic Best Practice” on how to do a Recall or Withdrawal through the EMVS, check it out: In English: https://lnkd.in/drbRF8WG Suomeksi: https://lnkd.in/dTQNtaEv #FightTheFakesWeek2024 #FTFweek #fakemeds #SFs #StopFakeMeds #FightTheFakes

🏥🚑Topic: 'Obstructive Shock' by Dr. Shri vishwapal Sivakumar 6th presentation from the FCPI Basic Module in Critical Care Medicine. 🖥️ Please register and log in from the FCPI website to attend the series of presentations in the FCPI Basic Module for FREE. Join live for this free webinar on 17th May (Friday) from 18.00 to 19.00 IST and participate in the Q&A session to get answers to your questions from the presentation. 🎟️An attendance certificate will be provided within 14 working days for all participants who have submitted the feedback forms. All presentation slides, handouts, and educational content will be freely downloadable from your account after logging in. 📩If you have any questions, please reach out to us at fcpiofficial@gmail.com 🧐If interested in FREE, high-quality educational content, please sign up through the FCPI website. For more updates, follow our social media. #fcpi #criticalcaremedicine #clinicalpharmacist #pharmd #criticalcare #criticalcarepharmacist #pharmacystudent #pharmacists

Tapering benzodiazepines safely and effectively is complex and often involves patient specific considerations. Luckily, ASAM has released a first draft of clinical guidelines for tapering benzos. Take a look!

Check out the latest learning from the Quality Use of Medicines Alliance, brought to you by Pharmaceutical Society of Australia. This online module will empower Pharmacists to have the confidence to provide evidence-based recommendation for the management of eczema. #qumalliance